{"transactions":[{"id":4613228,"issuer":{"id":3062,"kind":"organization","name":"AGILENT TECHNOLOGIES, INC.","symbol":"A"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-09-09T20:01:41.000Z","date":"2026-09-04","kind":"sale","planned":false,"acquired":false,"shares":634,"price":151.375,"value":95971.75,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 9.295 shares acquired under the Agilent Technologies, Inc. dividend reinvestment plan in transactions exempt under Rule 16a-11. The reporting person has elected to defer these shares of common stock."}],"balance_after":4923.68,"source":{"system":"sec-edgar","filing":"0001090872-26-000065","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437590/000109087226000065/form4.xml","form_type":"4"}},{"id":715055,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-06T23:59:59.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":64860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 64,860 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 18, 2027."}],"balance_after":64860,"derivative":{"exercise_price":3.35,"expiration_date":"2036-06-18","underlying":"Common Stock","underlying_shares":64860},"source":{"system":"sec-edgar","filing":"0001140361-26-027679","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437590/000114036126027679/form4.xml","form_type":"4"}},{"id":715054,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-07-06T23:59:59.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":22862,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units (\"RSUs\") that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2027."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This option represents a right to purchase a total of 64,860 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 18, 2027."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option represents a right to purchase a total of 64,860 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 18, 2027."}],"balance_after":67082,"source":{"system":"sec-edgar","filing":"0001140361-26-027679","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437590/000114036126027679/form4.xml","form_type":"4"}},{"id":755759,"issuer":{"id":3062,"kind":"organization","name":"AGILENT TECHNOLOGIES, INC.","symbol":"A"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-02T20:01:41.000Z","date":"2026-05-29","kind":"sale","planned":false,"acquired":false,"shares":1600,"price":135.42,"value":216672.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 10.175 shares acquired under the Agilent Technologies, Inc. dividend reinvestment plan in transactions exempt under Rule 16a-11. The reporting person has elected to defer these shares of common stock."}],"balance_after":5548.385,"source":{"system":"sec-edgar","filing":"0001090872-26-000057","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1090872/000109087226000057/form4.xml","form_type":"4"}},{"id":779074,"issuer":{"id":47322,"kind":"organization","name":"Apellis Pharmaceuticals, Inc.","symbol":"APLS"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-14T23:34:04.000Z","date":"2026-05-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":24135,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the terms of the Merger Agreement, effective as of immediately prior to the Effective Time, each outstanding and unexercised option to purchase shares of Common Stock that was vested pursuant to its existing terms or that vested as a result of the transactions contemplated by the Merger Agreement (each, a \"Cash-Out Option\") and had an exercise price per share that was less than $41.00 (the Cash Amount) was automatically cancelled and converted into the right to receive (i) an amount of cash, without interest and less applicable tax withholding, equal to the product of (x) the total number of shares of Common Stock underlying such option, multiplied by (y) the excess of the Cash Amount over the exercise price per share of such option and (ii) one CVR for each share of Common Stock underlying such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Pursuant to the terms of the Merger Agreement, effective as of immediately prior to the Effective Time, each outstanding and unexercised option to purchase shares of Common Stock that was vested pursuant to its existing terms or that vested as a result of the transactions contemplated by the Merger Agreement (each, a \"Cash-Out Option\") and had an exercise price per share that was less than $41.00 (the Cash Amount) was automatically cancelled and converted into the right to receive (i) an amount of cash, without interest and less applicable tax withholding, equal to the product of (x) the total number of shares of Common Stock underlying such option, multiplied by (y) the excess of the Cash Amount over the exercise price per share of such option and (ii) one CVR for each share of Common Stock underlying such option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Pursuant to the terms of the Merger Agreement, effective as of immediately prior to the Effective Time, each outstanding and unexercised option to purchase shares of Common Stock that was vested pursuant to its existing terms or that vested as a result of the transactions contemplated by the Merger Agreement (each, a \"Cash-Out Option\") and had an exercise price per share that was less than $41.00 (the Cash Amount) was automatically cancelled and converted into the right to receive (i) an amount of cash, without interest and less applicable tax withholding, equal to the product of (x) the total number of shares of Common Stock underlying such option, multiplied by (y) the excess of the Cash Amount over the exercise price per share of such option and (ii) one CVR for each share of Common Stock underlying such option."}],"balance_after":0,"derivative":{"exercise_price":20.96,"underlying":"Common Stock","underlying_shares":24135},"source":{"system":"sec-edgar","filing":"0001193125-26-224624","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492422/000119312526224624/ownership.xml","form_type":"4"}},{"id":779073,"issuer":{"id":47322,"kind":"organization","name":"Apellis Pharmaceuticals, Inc.","symbol":"APLS"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-14T23:34:04.000Z","date":"2026-05-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":14312,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, effective as of immediately prior to the Effective Time, each Converted RSU Award that was subject solely to a time-based vesting schedule (including, for the avoidance of doubt, any Converted RSU Award for which the performance period of any applicable performance metric had already ended) was automatically cancelled and converted into the contingent right to receive (i) an amount of cash, without interest and less applicable tax withholding, equal to the product of (x) the total number of shares of Common Stock underlying such Converted RSU Award multiplied by (y) the Cash Amount and (ii) one CVR for each share of Common Stock underlying such Converted RSU Award."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"(continued from footnote 4) Subject to the holder's continued service through the vesting dates applicable to the Converted RSU Award under its terms as in effect immediately prior to the Effective Time, all payments in respect of such Converted RSU Award pursuant to the Merger Agreement will vest and become payable at the same time as the underlying Converted RSU Award would have vested and become settled pursuant to its terms and shall otherwise remain subject to the same terms and conditions (including any \"double-trigger\" vesting provisions applicable to the Converted RSU Award immediately prior to the Effective Time, as extended as provided by the Merger Agreement) as were applicable to the underlying RSU immediately prior to the Effective Time and the terms of the CVR Agreement."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Pursuant to the terms of the Merger Agreement, effective as of immediately prior to the Effective Time, each Converted RSU Award that was subject solely to a time-based vesting schedule (including, for the avoidance of doubt, any Converted RSU Award for which the performance period of any applicable performance metric had already ended) was automatically cancelled and converted into the contingent right to receive (i) an amount of cash, without interest and less applicable tax withholding, equal to the product of (x) the total number of shares of Common Stock underlying such Converted RSU Award multiplied by (y) the Cash Amount and (ii) one CVR for each share of Common Stock underlying such Converted RSU Award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"(continued from footnote 4) Subject to the holder's continued service through the vesting dates applicable to the Converted RSU Award under its terms as in effect immediately prior to the Effective Time, all payments in respect of such Converted RSU Award pursuant to the Merger Agreement will vest and become payable at the same time as the underlying Converted RSU Award would have vested and become settled pursuant to its terms and shall otherwise remain subject to the same terms and conditions (including any \"double-trigger\" vesting provisions applicable to the Converted RSU Award immediately prior to the Effective Time, as extended as provided by the Merger Agreement) as were applicable to the underlying RSU immediately prior to the Effective Time and the terms of the CVR Agreement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-224624","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492422/000119312526224624/ownership.xml","form_type":"4"}},{"id":779072,"issuer":{"id":47322,"kind":"organization","name":"Apellis Pharmaceuticals, Inc.","symbol":"APLS"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-14T23:34:04.000Z","date":"2026-05-14","kind":"other","planned":false,"acquired":false,"shares":14312,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of that certain Agreement and Plan of Merger (the \"Merger Agreement\"), by and among Apellis Pharmaceuticals, Inc. (the \"Issuer\"), Biogen Inc. (\"Parent\") and Parent's direct wholly-owned subsidiary, Aspen Purchaser Sub, Inc. (\"Purchaser\"), dated as of March 31, 2026, the shares of common stock, par value $0.0001 per share, of the Issuer (the \"Common Stock\") that were tendered to Purchaser prior to the expiration time of the tender offer were exchanged for: (i) $41.00 per share of Common Stock, net to the seller in cash, without interest and subject to reduction for any applicable tax withholding (the \"Cash Amount\"), plus (ii) one contractual, non-transferable contingent value right per share of Common Stock (each, a \"CVR\"),"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from footnote 1) which entitles the holder to receive potential payments of up to an aggregate of $4.00 in cash, without interest and subject to reduction for any applicable tax withholding, upon the achievement of certain specified milestones in accordance with the terms and conditions of a contingent value rights agreement (the \"CVR Agreement\" and the Cash Amount plus one CVR, together, the \"Offer Price\"). After completion of the tender offer, pursuant to the terms of the Merger Agreement, Purchaser merged with and into the Issuer (the \"Merger\"), effective as of the filing and acceptance of the certificate of merger relating thereto on May 14, 2026 (the \"Effective Time\"), with the Issuer continuing as the surviving corporation (the \"Surviving Corporation\") and a wholly owned subsidiary of Parent. In the Merger, each share of Common Stock issued and outstanding immediately prior to the Effective Time, subject to certain exceptions,"},{"field":"kind","element":"transactionCoding","label":"F3","text":"(continued from footnote 2) was automatically converted into the  right to receive the Offer Price from Purchaser, without interest and subject to reduction for any applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of that certain Agreement and Plan of Merger (the \"Merger Agreement\"), by and among Apellis Pharmaceuticals, Inc. (the \"Issuer\"), Biogen Inc. (\"Parent\") and Parent's direct wholly-owned subsidiary, Aspen Purchaser Sub, Inc. (\"Purchaser\"), dated as of March 31, 2026, the shares of common stock, par value $0.0001 per share, of the Issuer (the \"Common Stock\") that were tendered to Purchaser prior to the expiration time of the tender offer were exchanged for: (i) $41.00 per share of Common Stock, net to the seller in cash, without interest and subject to reduction for any applicable tax withholding (the \"Cash Amount\"), plus (ii) one contractual, non-transferable contingent value right per share of Common Stock (each, a \"CVR\"),"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(continued from footnote 1) which entitles the holder to receive potential payments of up to an aggregate of $4.00 in cash, without interest and subject to reduction for any applicable tax withholding, upon the achievement of certain specified milestones in accordance with the terms and conditions of a contingent value rights agreement (the \"CVR Agreement\" and the Cash Amount plus one CVR, together, the \"Offer Price\"). After completion of the tender offer, pursuant to the terms of the Merger Agreement, Purchaser merged with and into the Issuer (the \"Merger\"), effective as of the filing and acceptance of the certificate of merger relating thereto on May 14, 2026 (the \"Effective Time\"), with the Issuer continuing as the surviving corporation (the \"Surviving Corporation\") and a wholly owned subsidiary of Parent. In the Merger, each share of Common Stock issued and outstanding immediately prior to the Effective Time, subject to certain exceptions,"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"(continued from footnote 2) was automatically converted into the  right to receive the Offer Price from Purchaser, without interest and subject to reduction for any applicable withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-224624","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492422/000119312526224624/ownership.xml","form_type":"4"}},{"id":831407,"issuer":{"id":3062,"kind":"organization","name":"AGILENT TECHNOLOGIES, INC.","symbol":"A"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-03-23T20:05:49.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":2158,"price":111.75,"value":241156.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant. The reporting person has elected to defer receipt of 1,079 shares of common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"7.182 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan. The reporting person has elected to defer these shares of common stock."}],"balance_after":7138.21,"source":{"system":"sec-edgar","filing":"0001090872-26-000027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1090872/000109087226000027/form4.xml","form_type":"4"}},{"id":866964,"issuer":{"id":47322,"kind":"organization","name":"Apellis Pharmaceuticals, Inc.","symbol":"APLS"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-03T21:06:32.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":24135,"price":20.96,"value":505869.6,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This represents a stock option award granted February 27, 2026 that vest 1/3rd per year over a three-year period subject to continued service."}],"balance_after":24135,"derivative":{"exercise_price":20.96,"expiration_date":"2036-02-27","underlying":"Common Stock","underlying_shares":24135},"source":{"system":"sec-edgar","filing":"0001492422-26-000092","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492422/000149242226000092/form4.xml","form_type":"4"}},{"id":866963,"issuer":{"id":47322,"kind":"organization","name":"Apellis Pharmaceuticals, Inc.","symbol":"APLS"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-03-03T21:06:32.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":14312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This restricted stock unit was granted on February 27, 2026. The restricted stock unit will fully vest on the first anniversary of the date of grant, subject to his continued service as a director, or upon later termination of his service as a director at his election."}],"balance_after":14312,"source":{"system":"sec-edgar","filing":"0001492422-26-000092","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492422/000149242226000092/form4.xml","form_type":"4"}},{"id":982417,"issuer":{"id":3062,"kind":"organization","name":"AGILENT TECHNOLOGIES, INC.","symbol":"A"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-03T21:04:44.000Z","date":"2025-12-01","kind":"sale","planned":false,"acquired":false,"shares":2600,"price":149.812,"value":389511.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average sale price is $149.812 with a range of $149.80 to $149.84. The Reporting Person has provided to the Issuer, and undertakes to provide any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 23.092 shares acquired under the Agilent Technologies, Inc. dividend reinvestment plan in transactions exempt under Rule 16a-11. The reporting person has elected to defer these shares of common stock."}],"balance_after":4973.028,"source":{"system":"sec-edgar","filing":"0001090872-25-000083","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1090872/000109087225000083/form4.xml","form_type":"4"}},{"id":1084655,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-07-18T20:05:42.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include 14,220 restricted stock units (\"RSUs\") that convert to common stock on a one-for-one basis held by the Reporting Person which cliff vest on December 31, 2025."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents RSUs that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents RSUs that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2026."}],"balance_after":44220,"source":{"system":"sec-edgar","filing":"0001140361-25-026409","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437590/000114036125026409/form4.xml","form_type":"4"}},{"id":1166334,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-04-24T20:06:21.000Z","date":"2025-03-05","kind":"other","planned":false,"acquired":true,"shares":14220,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represent restricted stock units (\"RSUs\") that convert to common stock on a one-for-one basis. The RSUs will become fully vested on December 31, 2025."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Rocket Pharmaceuticals, Inc. (the \"Company\") entered into a consulting agreement with the Reporting Person, effective March 3, 2025, for services related to the Company's research and development activities. As part of the compensation for services rendered, the Reporting Person received $125,000 of RSUs valued based on the closing price of the Company's common stock on March 3, 2025, which will cliff vest on December 31, 2025."}],"balance_after":14220,"source":{"system":"sec-edgar","filing":"0001140361-25-015425","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437590/000114036125015425/form4.xml","form_type":"4"}},{"id":1201693,"issuer":{"id":3062,"kind":"organization","name":"AGILENT TECHNOLOGIES, INC.","symbol":"A"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-03-18T13:58:16.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":1819,"price":121.18,"value":220426.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant. The reporting person has elected to defer receipt of 909.5 shares of common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"19.738 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan. The reporting person has elected to defer these shares of common stock."}],"balance_after":7549.936,"source":{"system":"sec-edgar","filing":"0001127602-25-009721","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1090872/000112760225009721/form4.xml","form_type":"4"}},{"id":330724,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Stock Appreciation Rights","published_at":"2024-09-16T16:56:42.000Z","date":"2024-09-12","kind":"grant","planned":false,"acquired":true,"shares":126794,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of issuer common stock underlying stock appreciation rights (\"total shareholder return units\" or \"TSRUs\") eligible for modification (\"Eligible TSRUs\") pursuant to the issuer's one-time offer to modify Eligible TSRUs (the \"Modification Offer\") described in the Tender Offer Statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on August 12, 2024 (as amended, the \"Schedule TO\") that the reporting person elected to modify. The Modification Offer provided eligible participants the opportunity to elect to modify certain outstanding TSRUs to extend the dates upon which the awards vest and settle by two years (the \"Modified TSRUs\"). The grant price and number of shares underlying the Modified TSRUs remain unchanged."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Reflects a modification to the settlement date of the Modified TSRUs pursuant to the Modification Offer. The grant price and number of shares underlying the Modified TSRUs remain unchanged."}],"balance_after":126794,"derivative":{"exercise_price":45.96,"exercise_date":"2029-02-24","expiration_date":"2029-02-24","underlying":"Common Stock","underlying_shares":126794},"source":{"system":"sec-edgar","filing":"0001225208-24-008704","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520824008704/doc4.xml","form_type":"4"}},{"id":330723,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Stock Appreciation Rights","published_at":"2024-09-16T16:56:42.000Z","date":"2024-09-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":126794,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":45.96,"exercise_date":"2027-02-24","expiration_date":"2027-02-24","underlying":"Common Stock","underlying_shares":126794},"source":{"system":"sec-edgar","filing":"0001225208-24-008704","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520824008704/doc4.xml","form_type":"4"}},{"id":330722,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Stock Appreciation Rights","published_at":"2024-09-16T16:56:42.000Z","date":"2024-09-12","kind":"grant","planned":false,"acquired":true,"shares":137760,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of issuer common stock underlying stock appreciation rights (\"total shareholder return units\" or \"TSRUs\") eligible for modification (\"Eligible TSRUs\") pursuant to the issuer's one-time offer to modify Eligible TSRUs (the \"Modification Offer\") described in the Tender Offer Statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on August 12, 2024 (as amended, the \"Schedule TO\") that the reporting person elected to modify. The Modification Offer provided eligible participants the opportunity to elect to modify certain outstanding TSRUs to extend the dates upon which the awards vest and settle by two years (the \"Modified TSRUs\"). The grant price and number of shares underlying the Modified TSRUs remain unchanged."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Reflects a modification to the settlement date of the Modified TSRUs pursuant to the Modification Offer. The grant price and number of shares underlying the Modified TSRUs remain unchanged."}],"balance_after":137760,"derivative":{"exercise_price":42.3,"exercise_date":"2030-02-23","expiration_date":"2030-02-23","underlying":"Common Stock","underlying_shares":137760},"source":{"system":"sec-edgar","filing":"0001225208-24-008704","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520824008704/doc4.xml","form_type":"4"}},{"id":330721,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Stock Appreciation Rights","published_at":"2024-09-16T16:56:42.000Z","date":"2024-09-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":137760,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":42.3,"exercise_date":"2028-02-23","expiration_date":"2028-02-23","underlying":"Common Stock","underlying_shares":137760},"source":{"system":"sec-edgar","filing":"0001225208-24-008704","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520824008704/doc4.xml","form_type":"4"}},{"id":1409634,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-11T20:07:06.000Z","date":"2024-09-09","kind":"grant","planned":false,"acquired":true,"shares":22988,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 22,988 shares of the Issuer's common stock, which will fully vest on September 9, 2025."}],"balance_after":22988,"derivative":{"exercise_price":19.73,"expiration_date":"2034-09-09","underlying":"Common Stock","underlying_shares":22988},"source":{"system":"sec-edgar","filing":"0001140361-24-040838","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437590/000114036124040838/form4.xml","form_type":"4"}},{"id":1409633,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-11T20:07:06.000Z","date":"2024-09-09","kind":"grant","planned":false,"acquired":true,"shares":27545,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 27,545 shares of the Issuer's common stock, which will vest in equal monthly installments over a three-year period, such that all of the shares underlying this option will be fully vested on September 9, 2027."}],"balance_after":27545,"derivative":{"exercise_price":19.73,"expiration_date":"2034-09-09","underlying":"Common Stock","underlying_shares":27545},"source":{"system":"sec-edgar","filing":"0001140361-24-040838","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437590/000114036124040838/form4.xml","form_type":"4"}},{"id":1570452,"issuer":{"id":3062,"kind":"organization","name":"AGILENT TECHNOLOGIES, INC.","symbol":"A"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-03-19T22:20:40.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":1678,"price":147.48,"value":247471.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant. The reporting person has elected to defer receipt of 839 shares of common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"15.196 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan. The reporting person has elected to defer these shares of common stock."}],"balance_after":5711.198,"source":{"system":"sec-edgar","filing":"0001127602-24-010682","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1090872/000112760224010682/form4.xml","form_type":"4"}},{"id":338695,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2024-02-29T11:53:32.000Z","date":"2024-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":21437,"price":27.04,"value":579656.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the settlement of stock units from previously exercised stock appreciation rights (including dividend equivalents thereon)."}],"balance_after":321729,"source":{"system":"sec-edgar","filing":"0001225208-24-003244","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520824003244/doc4.xml","form_type":"4"}},{"id":338875,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Stock Appreciation Rights","published_at":"2024-02-28T22:00:05.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":189867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant."}],"balance_after":189867,"derivative":{"exercise_price":26.89,"exercise_date":"2031-02-27","expiration_date":"2031-02-27","underlying":"Common Stock","underlying_shares":189867},"source":{"system":"sec-edgar","filing":"0001225208-24-003204","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520824003204/doc4.xml","form_type":"4"}},{"id":338874,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Stock Appreciation Rights","published_at":"2024-02-28T22:00:05.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":214880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant."}],"balance_after":214880,"derivative":{"exercise_price":26.89,"exercise_date":"2029-02-27","expiration_date":"2029-02-27","underlying":"Common Stock","underlying_shares":214880},"source":{"system":"sec-edgar","filing":"0001225208-24-003204","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520824003204/doc4.xml","form_type":"4"}},{"id":339012,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2024-02-27T18:46:28.000Z","date":"2024-02-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":24822,"price":27.76,"value":689058.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the settlement of stock units from previously exercised stock appreciation rights (including dividend equivalents thereon)."}],"balance_after":343166,"source":{"system":"sec-edgar","filing":"0001225208-24-003051","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520824003051/doc4.xml","form_type":"4"}},{"id":343451,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Phantom Stock Units","published_at":"2023-12-19T21:37:40.000Z","date":"2023-12-15","kind":"other","planned":false,"acquired":true,"shares":37552,"price":26.63,"value":1000009.76,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"This transaction constitutes an intra-plan transfer to acquire Pfizer stock units in the Pfizer stock unit fund under the Pfizer Inc. Deferred Compensation Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The units, held under the Deferred Compensation Plan, are paid in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The units, held under the Deferred Compensation Plan, are paid in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":87581,"derivative":{"underlying":"Common Stock","underlying_shares":37552},"source":{"system":"sec-edgar","filing":"0001225208-23-011271","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520823011271/doc4.xml","form_type":"4"}},{"id":1945054,"issuer":{"id":3062,"kind":"organization","name":"AGILENT TECHNOLOGIES, INC.","symbol":"A"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-21T01:38:54.000Z","date":"2023-03-16","kind":"grant","planned":false,"acquired":true,"shares":1658,"price":136.82,"value":226847.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant. The reporting person has elected to defer receipt of 829 shares of common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"7.564 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan. The reporting person has elected to defer these shares of common stock."}],"balance_after":4018.002,"source":{"system":"sec-edgar","filing":"0000899243-23-009221","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1090872/000089924323009221/doc4.xml","form_type":"4"}},{"id":352320,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2023-02-28T13:24:42.000Z","date":"2023-02-25","kind":"tax_withholding","acquired":false,"shares":37078,"price":41.75,"value":1548006.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the settlement of stock units from previously exercised stock appreciation rights (including dividend equivalents thereon)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price is the closing price of Pfizer common stock on February 24, 2023."}],"balance_after":354145,"source":{"system":"sec-edgar","filing":"0001225208-23-002917","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520823002917/doc4.xml","form_type":"4"}},{"id":352519,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Stock Appreciation Rights","published_at":"2023-02-25T01:18:31.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":119894,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant."}],"balance_after":119894,"derivative":{"exercise_price":42.3,"exercise_date":"2030-02-23","expiration_date":"2030-02-23","underlying":"Common Stock","underlying_shares":119894},"source":{"system":"sec-edgar","filing":"0001225208-23-002811","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520823002811/doc4.xml","form_type":"4"}},{"id":352518,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Stock Appreciation Rights","published_at":"2023-02-25T01:18:31.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":137760,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant."}],"balance_after":137760,"derivative":{"exercise_price":42.3,"exercise_date":"2028-02-23","expiration_date":"2028-02-23","underlying":"Common Stock","underlying_shares":137760},"source":{"system":"sec-edgar","filing":"0001225208-23-002811","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520823002811/doc4.xml","form_type":"4"}},{"id":352517,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2023-02-25T01:18:31.000Z","date":"2023-02-22","kind":"tax_withholding","acquired":false,"shares":32592,"price":42.38,"value":1381248.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the settlement of stock units from previously exercised stock appreciation rights (including dividend equivalents thereon)."}],"balance_after":391223,"source":{"system":"sec-edgar","filing":"0001225208-23-002811","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520823002811/doc4.xml","form_type":"4"}},{"id":356768,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Stock Appreciation Rights","published_at":"2022-11-09T21:08:54.000Z","date":"2022-11-07","kind":"exercise","acquired":false,"shares":133430,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":38.71,"exercise_date":"2022-02-28","expiration_date":"2026-02-28","underlying":"Common Stock","underlying_shares":133430},"source":{"system":"sec-edgar","filing":"0001225208-22-011483","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520822011483/doc4.xml","form_type":"4"}},{"id":356767,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Stock Appreciation Rights","published_at":"2022-11-09T21:08:54.000Z","date":"2022-11-07","kind":"exercise","acquired":false,"shares":127146,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":30.17,"exercise_date":"2021-02-22","expiration_date":"2025-02-22","underlying":"Common Stock","underlying_shares":127146},"source":{"system":"sec-edgar","filing":"0001225208-22-011483","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520822011483/doc4.xml","form_type":"4"}},{"id":356766,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2022-11-09T21:08:54.000Z","date":"2022-11-07","kind":"exercise","acquired":true,"shares":28170,"price":38.71,"value":1090460.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of stock units received upon the exercise and conversion of previously granted stock appreciation rights (SARs), calculated by taking the change in Pfizer common stock price (20 trading day average ending on the exercise date (Election Price of $45.07)) less the grant price of the SAR plus accumulated dividends from the grant date, times the number of SARs exercised. This value is divided by the Election Price to determine the number of stock units. The stock units and accumulated dividend units will be settled in Pfizer common stock on the SAR original settlement date, the seventh anniversary of grant."}],"balance_after":420007,"source":{"system":"sec-edgar","filing":"0001225208-22-011483","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520822011483/doc4.xml","form_type":"4"}},{"id":356765,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2022-11-09T21:08:54.000Z","date":"2022-11-07","kind":"exercise","acquired":true,"shares":50938,"price":30.17,"value":1536799.46,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of stock units received upon the exercise and conversion of previously granted stock appreciation rights (SARs), calculated by taking the change in Pfizer common stock price (20 trading day average ending on the exercise date (Election Price of $45.07)) less the grant price of the SAR plus accumulated dividends from the grant date, times the number of SARs exercised. This value is divided by the Election Price to determine the number of stock units. The stock units and accumulated dividend units will be settled in Pfizer common stock on the SAR original settlement date, the seventh anniversary of grant."}],"balance_after":391837,"source":{"system":"sec-edgar","filing":"0001225208-22-011483","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520822011483/doc4.xml","form_type":"4"}},{"id":361538,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Phantom Stock Units SSP","published_at":"2022-05-12T20:34:07.000Z","date":"2022-05-11","kind":"other","acquired":true,"shares":15167,"price":49.45,"value":750008.15,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"This transaction constitutes an intra-plan transfer into the Pfizer stock unit fund under the Pfizer Inc. Supplemental Savings Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":27380,"derivative":{"underlying":"Common Stock","underlying_shares":15167},"source":{"system":"sec-edgar","filing":"0001225208-22-006909","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520822006909/doc4.xml","form_type":"4"}},{"id":361537,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2022-05-12T20:34:07.000Z","date":"2022-05-11","kind":"sale","acquired":false,"shares":32015,"price":49.31,"value":1578659.65,"ownership":{"direct":true},"balance_after":333342,"source":{"system":"sec-edgar","filing":"0001225208-22-006909","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520822006909/doc4.xml","form_type":"4"}},{"id":361536,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2022-05-12T20:34:07.000Z","date":"2022-05-11","kind":"sale","acquired":false,"shares":18562,"price":49.32,"value":915477.84,"ownership":{"direct":true},"balance_after":365357,"source":{"system":"sec-edgar","filing":"0001225208-22-006909","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520822006909/doc4.xml","form_type":"4"}},{"id":361535,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2022-05-12T20:34:07.000Z","date":"2022-05-11","kind":"sale","acquired":false,"shares":7876,"price":49.33,"value":388523.08,"ownership":{"direct":true},"balance_after":383919,"source":{"system":"sec-edgar","filing":"0001225208-22-006909","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520822006909/doc4.xml","form_type":"4"}},{"id":361534,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2022-05-12T20:34:07.000Z","date":"2022-05-11","kind":"sale","acquired":false,"shares":2891,"price":49.35,"value":142670.85,"ownership":{"direct":true},"balance_after":391795,"source":{"system":"sec-edgar","filing":"0001225208-22-006909","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520822006909/doc4.xml","form_type":"4"}},{"id":361533,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2022-05-12T20:34:07.000Z","date":"2022-05-11","kind":"sale","acquired":false,"shares":2358,"price":49.34,"value":116343.72,"ownership":{"direct":true},"balance_after":394686,"source":{"system":"sec-edgar","filing":"0001225208-22-006909","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520822006909/doc4.xml","form_type":"4"}},{"id":361532,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2022-05-12T20:34:07.000Z","date":"2022-05-11","kind":"sale","acquired":false,"shares":200,"price":49.36,"value":9872.0,"ownership":{"direct":true},"balance_after":397044,"source":{"system":"sec-edgar","filing":"0001225208-22-006909","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520822006909/doc4.xml","form_type":"4"}},{"id":2323502,"issuer":{"id":3062,"kind":"organization","name":"AGILENT TECHNOLOGIES, INC.","symbol":"A"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-03-21T21:06:14.000Z","date":"2022-03-17","kind":"grant","acquired":true,"shares":1785,"price":136.82,"value":244223.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant. The reporting person has elected to defer receipt of 892 shares of common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"0.438 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan. The reporting person has elected to defer these shares of common stock."}],"balance_after":2352.438,"source":{"system":"sec-edgar","filing":"0001127602-22-010048","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1090872/000112760222010048/form4.xml","form_type":"4"}},{"id":364470,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Stock Appreciation Rights","published_at":"2022-03-04T21:13:12.000Z","date":"2022-03-03","kind":"exercise","acquired":false,"shares":158331,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":38.71,"exercise_date":"2022-02-28","expiration_date":"2024-02-28","underlying":"Common Stock","underlying_shares":158331},"source":{"system":"sec-edgar","filing":"0001225208-22-004229","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520822004229/doc4.xml","form_type":"4"}},{"id":364469,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Stock Appreciation Rights","published_at":"2022-03-04T21:13:12.000Z","date":"2022-03-03","kind":"exercise","acquired":false,"shares":127674,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":27.34,"exercise_date":"2020-02-23","expiration_date":"2024-02-23","underlying":"Common Stock","underlying_shares":127674},"source":{"system":"sec-edgar","filing":"0001225208-22-004229","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520822004229/doc4.xml","form_type":"4"}},{"id":364468,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2022-03-04T21:13:12.000Z","date":"2022-03-03","kind":"exercise","acquired":true,"shares":40438,"price":38.71,"value":1565354.98,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of stock units received upon the exercise and conversion of previously granted stock appreciation rights (SARs), calculated by taking the change in Pfizer common stock price (20 trading day average ending on the exercise date (Election Price of $49.36)) less the grant price of the SAR plus accumulated dividends from the grant date, times the number of SARs exercised. This value is divided by the Election Price to determine the number of stock units. The stock units and accumulated dividend units will be settled in Pfizer common stock on the SAR original settlement date, the fifth anniversary of grant."}],"balance_after":396578,"source":{"system":"sec-edgar","filing":"0001225208-22-004229","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520822004229/doc4.xml","form_type":"4"}},{"id":364467,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2022-03-04T21:13:12.000Z","date":"2022-03-03","kind":"exercise","acquired":true,"shares":62022,"price":27.34,"value":1695681.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of stock units received upon the exercise and conversion of previously granted stock appreciation rights (SARs), calculated by taking the change in Pfizer common stock price (20 trading day average ending on the exercise date (Election Price of $49.36)) less the grant price of the SAR plus accumulated dividends from the grant date, times the number of SARs exercised. This value is divided by the Election Price to determine the number of stock units. The stock units and accumulated dividend units will be settled in Pfizer common stock on the SAR original settlement date, the seventh anniversary of grant."}],"balance_after":356140,"source":{"system":"sec-edgar","filing":"0001225208-22-004229","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520822004229/doc4.xml","form_type":"4"}},{"id":364864,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2022-03-01T21:01:23.000Z","date":"2022-02-26","kind":"tax_withholding","acquired":false,"shares":29744,"price":47.72,"value":1419383.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the settlement of stock units from previously exercised stock appreciation rights (including dividend equivalents thereon)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price is the closing price of Pfizer common stock on February 25, 2022."}],"balance_after":294118,"source":{"system":"sec-edgar","filing":"0001225208-22-003662","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520822003662/doc4.xml","form_type":"4"}},{"id":365061,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Stock Appreciation Rights","published_at":"2022-02-25T23:40:18.000Z","date":"2022-02-24","kind":"grant","acquired":true,"shares":111516,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant."}],"balance_after":111516,"derivative":{"exercise_price":45.96,"exercise_date":"2029-02-24","expiration_date":"2029-02-24","underlying":"Common Stock","underlying_shares":111516},"source":{"system":"sec-edgar","filing":"0001225208-22-003473","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520822003473/doc4.xml","form_type":"4"}},{"id":365060,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Stock Appreciation Rights","published_at":"2022-02-25T23:40:18.000Z","date":"2022-02-24","kind":"grant","acquired":true,"shares":126794,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant."}],"balance_after":126794,"derivative":{"exercise_price":45.96,"exercise_date":"2027-02-24","expiration_date":"2027-02-24","underlying":"Common Stock","underlying_shares":126794},"source":{"system":"sec-edgar","filing":"0001225208-22-003473","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520822003473/doc4.xml","form_type":"4"}},{"id":365059,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2022-02-25T23:40:18.000Z","date":"2022-02-23","kind":"tax_withholding","acquired":false,"shares":29767,"price":46.87,"value":1395179.29,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the settlement of stock units from previously exercised stock appreciation rights (including dividend equivalents thereon)."}],"balance_after":323862,"source":{"system":"sec-edgar","filing":"0001225208-22-003473","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520822003473/doc4.xml","form_type":"4"}},{"id":368429,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Stock Appreciation Rights","published_at":"2021-12-21T23:31:55.000Z","date":"2021-12-17","kind":"exercise","acquired":false,"shares":152085,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":30.17,"exercise_date":"2021-02-22","expiration_date":"2023-02-22","underlying":"Common Stock","underlying_shares":152085},"source":{"system":"sec-edgar","filing":"0001225208-21-015184","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520821015184/doc4.xml","form_type":"4"}},{"id":368428,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Phantom Stock Units","published_at":"2021-12-21T23:31:55.000Z","date":"2021-12-17","kind":"other","acquired":false,"shares":25219,"price":59.48,"value":1500026.12,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each unit represents one phantom share of common stock."},{"field":"shares","element":"transactionShares","label":"F3","text":"The reporting person diversified shares held in the Pfizer Inc. Deferred Compensation Plan (Plan) pursuant to the Plan's diversification provision into an alternate investment option(s) under the Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The units, held under the Deferred Compensation Plan, are paid in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The units, held under the Deferred Compensation Plan, are paid in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":45983,"derivative":{"underlying":"Common Stock","underlying_shares":25219},"source":{"system":"sec-edgar","filing":"0001225208-21-015184","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520821015184/doc4.xml","form_type":"4"}},{"id":368427,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2021-12-21T23:31:55.000Z","date":"2021-12-17","kind":"exercise","acquired":true,"shares":71187,"price":30.17,"value":2147711.79,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of stock units received upon the exercise and conversion of previously granted stock appreciation rights (SARs), calculated by taking the change in Pfizer common stock price (20 trading day average ending on the exercise date (Election Price of $53.791)) less the grant price of the SAR plus accumulated dividends from the grant date, times the number of SARs exercised. This value is divided by the Election Price to determine the number of stock units. The stock units and accumulated dividend units will be settled in Pfizer common stock on the SAR original settlement date, the fifth anniversary of grant."}],"balance_after":351637,"source":{"system":"sec-edgar","filing":"0001225208-21-015184","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520821015184/doc4.xml","form_type":"4"}},{"id":369617,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Stock Appreciation Rights","published_at":"2021-11-15T22:40:30.000Z","date":"2021-11-11","kind":"exercise","acquired":false,"shares":127160,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":25.6,"exercise_date":"2018-02-26","expiration_date":"2022-02-26","underlying":"Common Stock","underlying_shares":127160},"source":{"system":"sec-edgar","filing":"0001225208-21-013883","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520821013883/doc4.xml","form_type":"4"}},{"id":369616,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Stock Appreciation Rights","published_at":"2021-11-15T22:40:30.000Z","date":"2021-11-11","kind":"exercise","acquired":false,"shares":145970,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":22.89,"exercise_date":"2019-02-25","expiration_date":"2023-02-25","underlying":"Common Stock","underlying_shares":145970},"source":{"system":"sec-edgar","filing":"0001225208-21-013883","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520821013883/doc4.xml","form_type":"4"}},{"id":369615,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Stock Appreciation Rights","published_at":"2021-11-15T22:40:30.000Z","date":"2021-11-11","kind":"exercise","acquired":false,"shares":153789,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":27.34,"exercise_date":"2020-02-23","expiration_date":"2022-02-23","underlying":"Common Stock","underlying_shares":153789},"source":{"system":"sec-edgar","filing":"0001225208-21-013883","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520821013883/doc4.xml","form_type":"4"}},{"id":369614,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Phantom Stock Units","published_at":"2021-11-15T22:40:30.000Z","date":"2021-11-11","kind":"other","acquired":false,"shares":47828,"price":50.18,"value":2400009.04,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each unit represents one phantom share of common stock."},{"field":"shares","element":"transactionShares","label":"F4","text":"The reporting person diversified shares held in the Pfizer Inc. Deferred Compensation Plan (\"Plan\") pursuant to the Plan's diversification provision into an alternate investment option(s) under the Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The units, held under the Deferred Compensation Plan, are paid in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The units, held under the Deferred Compensation Plan, are paid in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":71314,"derivative":{"underlying":"Common Stock","underlying_shares":47828},"source":{"system":"sec-edgar","filing":"0001225208-21-013883","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520821013883/doc4.xml","form_type":"4"}},{"id":369613,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2021-11-15T22:40:30.000Z","date":"2021-11-11","kind":"sale","acquired":false,"shares":36711,"price":50.28,"value":1845829.08,"ownership":{"direct":true},"balance_after":279842,"source":{"system":"sec-edgar","filing":"0001225208-21-013883","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520821013883/doc4.xml","form_type":"4"}},{"id":369612,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2021-11-15T22:40:30.000Z","date":"2021-11-11","kind":"sale","acquired":false,"shares":6708,"price":50.33,"value":337613.64,"ownership":{"direct":true},"balance_after":316553,"source":{"system":"sec-edgar","filing":"0001225208-21-013883","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520821013883/doc4.xml","form_type":"4"}},{"id":369611,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2021-11-15T22:40:30.000Z","date":"2021-11-11","kind":"sale","acquired":false,"shares":5227,"price":50.29,"value":262865.83,"ownership":{"direct":true},"balance_after":323261,"source":{"system":"sec-edgar","filing":"0001225208-21-013883","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520821013883/doc4.xml","form_type":"4"}},{"id":369610,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2021-11-15T22:40:30.000Z","date":"2021-11-11","kind":"sale","acquired":false,"shares":3396,"price":50.31,"value":170852.76,"ownership":{"direct":true},"balance_after":328488,"source":{"system":"sec-edgar","filing":"0001225208-21-013883","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520821013883/doc4.xml","form_type":"4"}},{"id":369609,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2021-11-15T22:40:30.000Z","date":"2021-11-11","kind":"sale","acquired":false,"shares":3197,"price":50.29,"value":160777.13,"ownership":{"direct":true},"balance_after":331884,"source":{"system":"sec-edgar","filing":"0001225208-21-013883","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520821013883/doc4.xml","form_type":"4"}},{"id":369608,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2021-11-15T22:40:30.000Z","date":"2021-11-11","kind":"sale","acquired":false,"shares":2301,"price":50.32,"value":115786.32,"ownership":{"direct":true},"balance_after":335081,"source":{"system":"sec-edgar","filing":"0001225208-21-013883","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520821013883/doc4.xml","form_type":"4"}},{"id":369607,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2021-11-15T22:40:30.000Z","date":"2021-11-11","kind":"sale","acquired":false,"shares":2124,"price":50.34,"value":106922.16,"ownership":{"direct":true},"balance_after":337382,"source":{"system":"sec-edgar","filing":"0001225208-21-013883","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520821013883/doc4.xml","form_type":"4"}},{"id":369606,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2021-11-15T22:40:30.000Z","date":"2021-11-11","kind":"exercise","acquired":true,"shares":58572,"price":25.6,"value":1499443.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of stock units received upon the exercise and conversion of previously granted stock appreciation rights (SARs), calculated by taking the change in Pfizer common stock price (20 trading day average ending on the exercise date (Election Price of $44.58)) less the grant price of the SAR plus accumulated dividends from the grant date, times the number of SARs exercised. This value is divided by the Election Price to determine the number of stock units. The stock units and accumulated dividend units will be settled in Pfizer common stock on the SAR original settlement date, the seventh anniversary of grant."}],"balance_after":339506,"source":{"system":"sec-edgar","filing":"0001225208-21-013883","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520821013883/doc4.xml","form_type":"4"}},{"id":369605,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2021-11-15T22:40:30.000Z","date":"2021-11-11","kind":"exercise","acquired":true,"shares":64841,"price":27.34,"value":1772752.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of stock units received upon the exercise and conversion of previously granted stock appreciation rights (SARs), calculated by taking the change in Pfizer common stock price (20 trading day average ending on the exercise date (Election Price of $44.58)) less the grant price of the SAR plus accumulated dividends from the grant date, times the number of SARs exercised. This value is divided by the Election Price to determine the number of stock units. The stock units and accumulated dividend units will be settled in Pfizer common stock on the SAR original settlement date, the fifth anniversary of grant."}],"balance_after":280934,"source":{"system":"sec-edgar","filing":"0001225208-21-013883","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520821013883/doc4.xml","form_type":"4"}},{"id":369604,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2021-11-15T22:40:30.000Z","date":"2021-11-11","kind":"exercise","acquired":true,"shares":76135,"price":22.89,"value":1742730.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of stock units received upon the exercise and conversion of previously granted stock appreciation rights (SARs), calculated by taking the change in Pfizer common stock price (20 trading day average ending on the exercise date (Election Price of $44.58)) less the grant price of the SAR plus accumulated dividends from the grant date, times the number of SARs exercised. This value is divided by the Election Price to determine the number of stock units. The stock units and accumulated dividend units will be settled in Pfizer common stock on the SAR original settlement date, the seventh anniversary of grant."}],"balance_after":216093,"source":{"system":"sec-edgar","filing":"0001225208-21-013883","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520821013883/doc4.xml","form_type":"4"}},{"id":2561223,"issuer":{"id":3062,"kind":"organization","name":"AGILENT TECHNOLOGIES, INC.","symbol":"A"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-09-23T20:25:37.000Z","date":"2021-09-22","kind":"grant","acquired":true,"shares":567,"price":172.44,"value":97773.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant."}],"balance_after":567,"source":{"system":"sec-edgar","filing":"0001127602-21-025723","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1090872/000112760221025723/form4.xml","form_type":"4"}},{"id":2700722,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2021-05-21T21:32:53.000Z","date":"2021-05-21","kind":"grant","acquired":true,"shares":23900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 100% of the underlying shares on the earlier of May 21, 2022 or the next annual meeting of stockholders of Karyopharm Therapeutics Inc. (the \"Issuer\"), provided that the reporting person continues to serve as a director of the Issuer through such date."}],"balance_after":23900,"derivative":{"exercise_price":9.42,"expiration_date":"2031-05-20","underlying":"Common Stock","underlying_shares":23900},"source":{"system":"sec-edgar","filing":"0001209191-21-035025","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437590/000120919121035025/doc4.xml","form_type":"4"}},{"id":379049,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2021-03-03T00:00:19.000Z","date":"2021-02-27","kind":"tax_withholding","acquired":false,"shares":23841,"price":33.49,"value":798435.09,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the settlement of stock units from previously exercised stock appreciation rights (including dividend equivalents thereon)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price is the closing price of Pfizer common stock on February 26, 2021."}],"balance_after":137727,"source":{"system":"sec-edgar","filing":"0001225208-21-004333","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520821004333/doc4.xml","form_type":"4"}},{"id":379050,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2021-03-02T23:57:18.000Z","date":"2021-02-25","kind":"tax_withholding","acquired":false,"shares":28271,"price":33.82,"value":956125.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the settlement of stock units from previously exercised stock appreciation rights (including dividend equivalents thereon)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This Form 4 is being amended to correct the number of securities beneficially owned following the reported transaction."}],"balance_after":161568,"source":{"system":"sec-edgar","filing":"0001225208-21-004332","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520821004332/doc4a.xml","form_type":"4/A","original_submission_date":"2021-03-01"}},{"id":379250,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Stock Appreciation Rights","published_at":"2021-03-01T21:01:34.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":182050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant."}],"balance_after":182050,"derivative":{"exercise_price":33.82,"exercise_date":"2028-02-25","expiration_date":"2028-02-25","underlying":"Common Stock","underlying_shares":182050},"source":{"system":"sec-edgar","filing":"0001225208-21-004042","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520821004042/doc4.xml","form_type":"4"}},{"id":379249,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Stock Appreciation Rights","published_at":"2021-03-01T21:01:34.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":210697,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant."}],"balance_after":210697,"derivative":{"exercise_price":33.82,"exercise_date":"2026-02-25","expiration_date":"2026-02-25","underlying":"Common Stock","underlying_shares":210697},"source":{"system":"sec-edgar","filing":"0001225208-21-004042","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520821004042/doc4.xml","form_type":"4"}},{"id":379248,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2021-03-01T21:01:34.000Z","date":"2021-02-25","kind":"tax_withholding","acquired":false,"shares":28271,"price":33.82,"value":956125.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the settlement of stock units from previously exercised stock appreciation rights (including dividend equivalents thereon)."}],"balance_after":156568,"source":{"system":"sec-edgar","filing":"0001225208-21-004042","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520821004042/doc4.xml","form_type":"4"}},{"id":3135030,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2020-05-26T20:20:17.000Z","date":"2020-05-21","kind":"grant","acquired":true,"shares":16400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 100% of the underlying shares on May 21, 2021, provided that the reporting person continues to serve as a director of the issuer through such date."}],"balance_after":16400,"derivative":{"exercise_price":19.11,"expiration_date":"2030-05-20","underlying":"Common Stock","underlying_shares":16400},"source":{"system":"sec-edgar","filing":"0001209191-20-032003","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437590/000120919120032003/doc4.xml","form_type":"4"}},{"id":390299,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2020-05-19T21:37:10.000Z","date":"2020-05-18","kind":"sale","acquired":false,"shares":24242,"price":37.79,"value":916105.18,"ownership":{"direct":true},"balance_after":174918,"source":{"system":"sec-edgar","filing":"0001225208-20-008008","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520820008008/doc4.xml","form_type":"4"}},{"id":390298,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2020-05-19T21:37:10.000Z","date":"2020-05-18","kind":"sale","acquired":false,"shares":17357,"price":37.78,"value":655747.46,"ownership":{"direct":true},"balance_after":199160,"source":{"system":"sec-edgar","filing":"0001225208-20-008008","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520820008008/doc4.xml","form_type":"4"}},{"id":390297,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2020-05-19T21:37:10.000Z","date":"2020-05-18","kind":"sale","acquired":false,"shares":16840,"price":37.8,"value":636552.0,"ownership":{"direct":true},"balance_after":216517,"source":{"system":"sec-edgar","filing":"0001225208-20-008008","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520820008008/doc4.xml","form_type":"4"}},{"id":390296,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2020-05-19T21:37:10.000Z","date":"2020-05-18","kind":"sale","acquired":false,"shares":14727,"price":37.77,"value":556238.79,"ownership":{"direct":true},"balance_after":233357,"source":{"system":"sec-edgar","filing":"0001225208-20-008008","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520820008008/doc4.xml","form_type":"4"}},{"id":390295,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2020-05-19T21:37:10.000Z","date":"2020-05-18","kind":"sale","acquired":false,"shares":9700,"price":37.75,"value":366175.0,"ownership":{"direct":true},"balance_after":248084,"source":{"system":"sec-edgar","filing":"0001225208-20-008008","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520820008008/doc4.xml","form_type":"4"}},{"id":390294,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2020-05-19T21:37:10.000Z","date":"2020-05-18","kind":"sale","acquired":false,"shares":6470,"price":37.81,"value":244630.7,"ownership":{"direct":true},"balance_after":257784,"source":{"system":"sec-edgar","filing":"0001225208-20-008008","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520820008008/doc4.xml","form_type":"4"}},{"id":390293,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2020-05-19T21:37:10.000Z","date":"2020-05-18","kind":"sale","acquired":false,"shares":5517,"price":37.76,"value":208321.92,"ownership":{"direct":true},"balance_after":264254,"source":{"system":"sec-edgar","filing":"0001225208-20-008008","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520820008008/doc4.xml","form_type":"4"}},{"id":390292,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2020-05-19T21:37:10.000Z","date":"2020-05-18","kind":"sale","acquired":false,"shares":500,"price":37.82,"value":18910.0,"ownership":{"direct":true},"balance_after":269771,"source":{"system":"sec-edgar","filing":"0001225208-20-008008","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520820008008/doc4.xml","form_type":"4"}},{"id":393914,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2020-03-03T17:54:38.000Z","date":"2020-02-28","kind":"tax_withholding","acquired":false,"shares":39446,"price":33.42,"value":1318285.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the settlement of stock units from previously exercised stock appreciation rights (including dividend equivalents thereon)."}],"balance_after":268515,"source":{"system":"sec-edgar","filing":"0001225208-20-004021","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520820004021/doc4.xml","form_type":"4"}},{"id":394169,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Stock Appreciation Rights","published_at":"2020-02-29T00:17:01.000Z","date":"2020-02-27","kind":"grant","acquired":true,"shares":182461,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant."}],"balance_after":182461,"derivative":{"exercise_price":34.1,"exercise_date":"2027-02-27","expiration_date":"2027-02-27","underlying":"Common Stock","underlying_shares":182461},"source":{"system":"sec-edgar","filing":"0001225208-20-003784","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520820003784/doc4.xml","form_type":"4"}},{"id":394168,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Stock Appreciation Rights","published_at":"2020-02-29T00:17:01.000Z","date":"2020-02-27","kind":"grant","acquired":true,"shares":212961,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant."}],"balance_after":212961,"derivative":{"exercise_price":34.1,"exercise_date":"2025-02-27","expiration_date":"2025-02-27","underlying":"Common Stock","underlying_shares":212961},"source":{"system":"sec-edgar","filing":"0001225208-20-003784","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520820003784/doc4.xml","form_type":"4"}},{"id":394167,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2020-02-29T00:17:01.000Z","date":"2020-02-26","kind":"tax_withholding","acquired":false,"shares":22314,"price":34.72,"value":774742.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon)."}],"balance_after":307961,"source":{"system":"sec-edgar","filing":"0001225208-20-003784","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520820003784/doc4.xml","form_type":"4"}},{"id":394166,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2020-02-29T00:17:01.000Z","date":"2020-02-26","kind":"tax_withholding","acquired":false,"shares":15478,"price":34.72,"value":537396.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the settlement of stock units from previously exercised stock appreciation rights (including dividend equivalents thereon)."}],"balance_after":330275,"source":{"system":"sec-edgar","filing":"0001225208-20-003784","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520820003784/doc4.xml","form_type":"4"}},{"id":394165,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2020-02-29T00:17:01.000Z","date":"2020-02-26","kind":"grant","acquired":true,"shares":45566,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon)."}],"balance_after":345753,"source":{"system":"sec-edgar","filing":"0001225208-20-003784","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520820003784/doc4.xml","form_type":"4"}},{"id":3497081,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2019-06-07T12:54:55.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 100% of the underlying shares on June 6, 2020, provided that the reporting person continues to serve as a director of the issuer through such date."}],"balance_after":25000,"derivative":{"exercise_price":5.43,"expiration_date":"2029-06-05","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-19-035374","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437590/000120919119035374/doc4.xml","form_type":"4"}},{"id":406209,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Stock Appreciation Rights","published_at":"2019-03-05T21:54:58.000Z","date":"2019-03-01","kind":"exercise","acquired":false,"shares":126366,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":32.23,"exercise_date":"2018-06-16","expiration_date":"2021-02-27","underlying":"Common Stock","underlying_shares":126366},"source":{"system":"sec-edgar","filing":"0001225208-19-004612","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520819004612/doc4.xml","form_type":"4"}},{"id":406208,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Stock Appreciation Rights","published_at":"2019-03-05T21:54:58.000Z","date":"2019-03-01","kind":"exercise","acquired":false,"shares":155172,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":30.59,"exercise_date":"2019-02-25","expiration_date":"2021-02-25","underlying":"Common Stock","underlying_shares":155172},"source":{"system":"sec-edgar","filing":"0001225208-19-004612","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520819004612/doc4.xml","form_type":"4"}},{"id":406207,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2019-03-05T21:54:58.000Z","date":"2019-03-04","kind":"sale","acquired":false,"shares":38645,"price":43.52,"value":1681830.4,"ownership":{"direct":true},"balance_after":289126,"source":{"system":"sec-edgar","filing":"0001225208-19-004612","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520819004612/doc4.xml","form_type":"4"}},{"id":406206,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2019-03-05T21:54:58.000Z","date":"2019-03-04","kind":"sale","acquired":false,"shares":3250,"price":43.53,"value":141472.5,"ownership":{"direct":true},"balance_after":327771,"source":{"system":"sec-edgar","filing":"0001225208-19-004612","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520819004612/doc4.xml","form_type":"4"}},{"id":406205,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2019-03-05T21:54:58.000Z","date":"2019-03-04","kind":"sale","acquired":false,"shares":2600,"price":43.54,"value":113204.0,"ownership":{"direct":true},"balance_after":331021,"source":{"system":"sec-edgar","filing":"0001225208-19-004612","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520819004612/doc4.xml","form_type":"4"}},{"id":406204,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2019-03-05T21:54:58.000Z","date":"2019-03-04","kind":"sale","acquired":false,"shares":2400,"price":43.55,"value":104520.0,"ownership":{"direct":true},"balance_after":333621,"source":{"system":"sec-edgar","filing":"0001225208-19-004612","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520819004612/doc4.xml","form_type":"4"}},{"id":406203,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2019-03-05T21:54:58.000Z","date":"2019-03-04","kind":"sale","acquired":false,"shares":2187,"price":43.56,"value":95265.72,"ownership":{"direct":true},"balance_after":336021,"source":{"system":"sec-edgar","filing":"0001225208-19-004612","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520819004612/doc4.xml","form_type":"4"}},{"id":406202,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2019-03-05T21:54:58.000Z","date":"2019-03-01","kind":"sale","acquired":false,"shares":77484,"price":43.56,"value":3375203.04,"ownership":{"direct":true},"balance_after":338208,"source":{"system":"sec-edgar","filing":"0001225208-19-004612","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520819004612/doc4.xml","form_type":"4"}},{"id":406201,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":15176,"kind":"person","name":"Dolsten Mikael","position":1,"cik":"0001437590","reported_name":"Dolsten Mikael","relationship":{"officer":true,"officer_title":"President R&D"}}],"security":"Common Stock","published_at":"2019-03-05T21:54:58.000Z","date":"2019-03-01","kind":"sale","acquired":false,"shares":14760,"price":43.57,"value":643093.2,"ownership":{"direct":true},"balance_after":415692,"source":{"system":"sec-edgar","filing":"0001225208-19-004612","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520819004612/doc4.xml","form_type":"4"}}],"next_cursor":"2019-03-05T21:54:58.000000Z,406201"}